ATE557276T1 - Spezifisches verfahren zum krebsnachweis - Google Patents

Spezifisches verfahren zum krebsnachweis

Info

Publication number
ATE557276T1
ATE557276T1 AT04791917T AT04791917T ATE557276T1 AT E557276 T1 ATE557276 T1 AT E557276T1 AT 04791917 T AT04791917 T AT 04791917T AT 04791917 T AT04791917 T AT 04791917T AT E557276 T1 ATE557276 T1 AT E557276T1
Authority
AT
Austria
Prior art keywords
specific method
detecting cancer
specific
qualitative
diagnosis
Prior art date
Application number
AT04791917T
Other languages
English (en)
Inventor
Patrizia Pontisso
Luca Beneduce
Giorgio Fassina
Maria Marino
Original Assignee
Xeptagen S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xeptagen S P A filed Critical Xeptagen S P A
Application granted granted Critical
Publication of ATE557276T1 publication Critical patent/ATE557276T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57565—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen [CEA]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
AT04791917T 2003-10-30 2004-10-26 Spezifisches verfahren zum krebsnachweis ATE557276T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000264A ITPD20030264A1 (it) 2003-10-30 2003-10-30 Metodo di diagnosi altamente specifico per neoplasie
PCT/IT2004/000583 WO2005043165A2 (en) 2003-10-30 2004-10-26 Specific method for cancer detection

Publications (1)

Publication Number Publication Date
ATE557276T1 true ATE557276T1 (de) 2012-05-15

Family

ID=34531934

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04791917T ATE557276T1 (de) 2003-10-30 2004-10-26 Spezifisches verfahren zum krebsnachweis

Country Status (4)

Country Link
EP (3) EP2367005A1 (de)
AT (1) ATE557276T1 (de)
IT (1) ITPD20030264A1 (de)
WO (1) WO2005043165A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136311A (en) 1996-05-06 2000-10-24 Cornell Research Foundation, Inc. Treatment and diagnosis of cancer
WO2007059313A1 (en) * 2005-11-16 2007-05-24 Children's Medical Center Corporation Method to assess breast cancer risk
EP1996716B1 (de) 2006-03-20 2011-05-11 The Regents of the University of California Manipulierte anti-prostatastammzellenantigen (psca)-antikörper für krebs-targeting
US8940298B2 (en) 2007-09-04 2015-01-27 The Regents Of The University Of California High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection
EP3495000A1 (de) 2009-02-17 2019-06-12 Cornell Research Foundation, Inc. Verfahren und kits zur diagnose von krebs und vorhersage des therapeutischen werts
EP2460012B1 (de) * 2009-07-29 2016-04-20 Randox Laboratories Ltd. Verfahren für den nachweis von blasenkrebs bzw. des risikos für blasenkrebs
MX337600B (es) 2009-12-02 2016-03-11 Imaginab Inc Minicuerpos j591 y diacuerpos-cys para apuntar con especificidad de objetivo a un antigeno de membrana especifico para prostata de humano (psma) y metodos para su uso.
WO2011085165A2 (en) * 2010-01-08 2011-07-14 The Brigham And Women's Hospital, Inc. Ca-125 immune complexes as biomarkers of ovarian cancer
AU2010365277B2 (en) * 2010-12-06 2017-01-05 Thd S.P.A. Method for the diagnosis of a carcinoma and uses thereof
CA2877721A1 (en) 2012-06-27 2014-01-03 Berg Llc Use of markers in the diagnosis and treatment of prostate cancer
GB201218570D0 (en) 2012-10-16 2012-11-28 Randox Lab Ltd Method
WO2015117956A1 (en) * 2014-02-04 2015-08-13 Celltrend Gmbh Diagnosis of cancer by detecting auto-antibodies against par1
US10261087B2 (en) 2014-02-04 2019-04-16 Celltrend Gmbh Diagnosis of cancer by detecting auto-antibodies against vascular endothelial growth factor (VEGF)
US10203343B2 (en) 2014-02-04 2019-02-12 Celltrend Gmbh Diagnosis of cancer by detecting auto-antibodies against epidermal growth factor (EGF)
WO2015117955A1 (en) * 2014-02-04 2015-08-13 Celltrend Gmbh Diagnosis of cancer by detecting auto-antibodies against vascular endothelialgrowth factor receptor (vegfr)
US10739346B2 (en) 2014-02-04 2020-08-11 Celltrend Gmbh Diagnosis of cancer by detecting auto-antibodies against EGF-receptor
CN104062437A (zh) * 2014-06-12 2014-09-24 上海交通大学医学院附属瑞金医院 Erbb2蛋白在制备检测嗜铬细胞瘤转移试剂中的应用
EP3230314B1 (de) 2014-12-08 2023-05-03 Berg LLC Verwendung von markern einschliesslich filamin a bei der diagnose und behandlung von prostatakrebs
CN104991065B (zh) * 2015-07-07 2017-01-11 复旦大学附属金山医院 一种用于诊断乳腺癌的三联标志物及其应用
KR20250008141A (ko) 2015-08-07 2025-01-14 이미지냅 인코포레이티드 분자를 표적화하기 위한 항원 결합 구조체
WO2017201225A1 (en) * 2016-05-19 2017-11-23 Poc Medical Systems, Inc. Cancer screening via detection and quantification of multiple biomarkers
CN106468711A (zh) * 2016-09-07 2017-03-01 北京热景生物技术股份有限公司 Dcp快速分离检测试剂盒
GB201619954D0 (en) * 2016-11-25 2017-01-11 Oncimmune Ltd Antibody assay
WO2018147960A1 (en) 2017-02-08 2018-08-16 Imaginab, Inc. Extension sequences for diabodies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5915858A (ja) * 1982-07-16 1984-01-26 Otsuka Pharmaceut Co Ltd 腫瘍関連抗原特異的免疫複合体の測定法
US4711839A (en) * 1985-01-11 1987-12-08 Imre Corporation Immune complex assay
EP0529007A1 (de) * 1990-04-18 1993-03-03 The Regents Of The University Of California 35 kd eumor-assoziiertes proteinantigen und immunkomplex
WO1994008597A1 (en) * 1992-10-14 1994-04-28 The Scripps Research Institute Methods for the detection of antigen-specific immune complexes
WO2001073437A2 (en) * 2000-03-27 2001-10-04 Diagen Corporation Antigen-specific enzyme-linked immunosorbent assay
IT1317355B1 (it) * 2000-07-28 2003-06-16 Xeptagen S R L Anticorpi policlonali.

Also Published As

Publication number Publication date
EP1678503B1 (de) 2012-05-09
EP2339345A1 (de) 2011-06-29
ITPD20030264A1 (it) 2005-04-30
EP1678503A2 (de) 2006-07-12
WO2005043165A2 (en) 2005-05-12
WO2005043165A3 (en) 2005-08-04
EP2367005A1 (de) 2011-09-21

Similar Documents

Publication Publication Date Title
ITPD20030264A1 (it) Metodo di diagnosi altamente specifico per neoplasie
CY1112631T1 (el) ΜΕΘΟΔΟΙ ΤΑΥΤΟΠΟΙΗΣΗΣ ΟΓΚΩΝ ΠΟΥ ΑΠΟΚΡΙΝΟΝΤΑΙ ΣΕ ΑΓΩΓΗ ΜΕ ΑΝΤΙΣΩΜΑΤΑ ΑΝΤΙ-ΕrbB2
DE602007009645D1 (de) Reagenzien und verfahren für krebsprognose und pathologische einstufung
ATE535805T1 (de) Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen
ATE438737T1 (de) Verfahren für den nachweis von erkrankungen
ATE551367T1 (de) Epha2-bindende antikörper und verfahren zu ihrer verwendung
DE60335022D1 (de) Internalisierende Antikörper spezifisch für das RAAG10 Zelloberflächenziel
DE602005017781D1 (de) Rekonstituierter histon-methyltransferase-komplex und verfahren zur identifizierung von modulatoren dafür
DE602006002809D1 (de) Verfahren zur erkennung eines ovarialkarzinoms
DE602004022943D1 (de) Verfahren zum nachweis von analyten auf grundlage von evaneszenzbelichtung und auf streuung beruhender nachweis von nanopartikelsondenkomplexen
ATE476525T1 (de) Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern
EA202091810A1 (ru) Антитела к b7-h4 и способы их применения
ATE517124T1 (de) Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 42- 46 bindet
ATE424560T1 (de) Marker für neuromyelitis optica
DE69535802D1 (de) Genetische veränderungen, die mit lungencarzinomen korrelieren
CA2839777C (en) Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
DE602005008787D1 (de) Nahrungsmittelanalysator für autonom angetriebene Futterstationen, sowie Verfahren dafür
ATE397098T1 (de) Verfahren zur diagnostik von eierstock endometriose
FR2933185B1 (fr) Systeme et procede de determination d'informations representatives du mouvement d'une chaine articulee
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
EP1924710A4 (de) Verfahren zur diagnose eines ovarialkarzinoms und kits dafür
CY1113013T1 (el) Βελτιωμενες μεθοδοι ανοσολογικων δοκιμασιων
DE10229760B4 (de) Positionsermittlungsverfahren für einen induktiven Positionssensor
DE60323677D1 (de) Verfahren zur bestimmung des wiederauftretens von prostata krebs
DE602004026439D1 (de) Lp-pla2-aktivitätstest mit hohem durchsatz